$178.09
+1.09 (+0.616%)
At Close: Jun 23, 2026
iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Upgraded by ValuEngine to Hold
10:34am, Sunday, 05'th Apr 2020
ValuEngine upgraded shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) from a sell rating to a hold rating in a research report sent to investors on Wednesday morning, ValuEngine reports. Shares
The Year of the Rat: Have They FED on Money Supply?
09:40am, Sunday, 05'th Apr 2020
Over the last three weeks, the M2 money supply has exploded by a whopping $532 billion. Money supply is expanding at 26x the rate of QE1 during the 2008 financial crisis.
Fulton Bank N.A. Buys 304 Shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)
10:44am, Saturday, 04'th Apr 2020
Fulton Bank N.A. lifted its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 2.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange
7 Promising Biotech Stocks in a Postpandemic World
10:34pm, Friday, 03'rd Apr 2020
Casdin Capital’s Eli Casdin highlights seven promising life-sciences stocks, including bluebird bio, Invitae, and Crispr Therapeutics
Sign In
Buy IBB